Involvement of distinct PKC gene products in T cell functions

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Pfeifhofer Obermair, Christa ^a   Thuille, Nikolaus ^a   Baier, Gottfried ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Immune disease therapy; PKC isotypes; Protein kinases; T cell regulation

Indexed keywords

EID: 84874215284     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00220     Document Type: Article

References (140)

1. Akita, Y. (2002). Protein kinase C-s: its unique structure and function. J. Biochem. 132, 847-852.
2. Barreiro Arcos, M. L., Gorelik, G., Klecha, A., Genaro, A. M., and Cremaschi, G. A. (2006). Thyroid hormones increase inducible nitric oxide synthase gene expression downstream from PKCi; in murine tumor T lymphocytes. Am. J. Physiol. Cell Physiol. 291, C327-C336.
3. Bauer, B., Krumbock, N., Fresser, F., Hochholdinger, F., Spitaler, M., Simm, A., Uberall, F., Schraven, B., and Baier, G. (2001). Complex formation and cooperation of protein kinase C 9 and Akt1/protein kinase B a in the NF-K B transactivation cascade in Jurkat T cells. J. Biol. Chem. 276, 31627-31634.
4. Bertolotto, C., Maulon, L., Filippa, N., Baier, G., and Auberger, P. (2000). Protein kinase C 9 and s promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD. J. Biol. Chem. 275, 37246-37250.
5. Bi, K., Tanaka, Y., Coudronniere, N., Sugie, K.,Hong, S.,VanStipdonk, M. J., and Altman, A. (2001). Antigen-induced translocation of PKC9 to membrane rafts is required for T cell activation. Nat. Immunol. 2, 556-563.
6. Bosch, R. R., Bazuine, M., Wake, M. M., Span, P. N., Olthaar, A. J., Schurmann, A., Maassen, J. A., Hermus, A. R., Willems, P. H., and Sweep, C. G. (2003). Inhibition of protein kinase CβII increases glucose uptake in 3T3-L1 adipocytes through elevated expression of glucose transporter 1 at the plasma membrane. Mol. Endocrinol. 17, 1230-1239.
7. Cabodi, S., Calautti, E., Talora, C., Kuroki, T., Stein, P. L., and Dotto, G. P. (2000). A PKC-eta/Fyn-dependent pathway leading to keratinocyte growth arrest and differentiation. Mol. Cell 6, 1121-1129.
8. Carman, C. V., and Springer, T. A. (2003). Integrin avidity regulation: are changes in affinity and conformation underemphasized? Curr. Opin. Cell Biol. 15, 547-556.
9. Castrillo, A., Pennington, D. J., Otto, F., Parker, P. J., Owen, M. J., and Boscá, L. (2001). Protein kinase Cepsilon is required for macrophage activation and defense against bacterial infection.J. Exp. Med. 194, 1231-1242.
10. Cerda, S. R., Bissonnette, M., Scaglione-Sewell, B., Lyons, M. R., Khare, S., Mustafi, R., and Brasitus, T. A. (2001). PKCS inhibits anchorage-dependent and -independent growth, enhances differentiation, and increases apopto-sis in CaCo-2 cells. Gastroenterology 120, 1700-1712.
11. Cervino, M. C, Lopez-Lago, M. A., Vinuela, J. E., and Barja, P. (2010). Specific inhibition of protein kinase Cbeta expression by antisense RNA affects the activation of Jurkat T lymphoma cells. J. Biol. Regul. Homeost. Agents 24,273-285.
12. Chida, K., Hara, T., Hirai, T., Konishi, C., Nakamura, K., Nakao, K., Aiba, A., Katsuki, M., and Kuroki, T. (2003). Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res. 63, 2404-2408.
13. Chida, K., Nakada, T., Otsuka, H., Kuroki, T., and Satoh, H. (1998). Assignment of protein kinase C eta (Pkch) to mouse chromosome band 12C3-D2 by in situ hybridization. Cytogenet. Cell Genet. 82, 30-31.
14. Chuang, H. C, Lan, J. L., Chen, D. Y, Yang, C. Y, Chen, Y M., Li, J. P., Huang, C. Y, Liu, P. E., Wang, X., Tan, T. H. (2011). The kinase GLK controls autoimmunity and NF-KB signaling by activating the kinase PKC-9 in T cells. Nat. Immunol. 12,1113-1118.
15. Denis, F. M., Benecke, A., Di Gioia, Y, Touw, I. P.,Cayre,Y E.,andLutz, P. G. (2005). PRAM-1 potentiates arsenic trioxide-induced JNK activation. J. Biol. Chem. 280, 9043-9048.
16. Dreikhausen, U. E., Gorf, K., Resch, K., and Szamel, M. (2003). Protein kinase Cβ1, a major regulator of TCR-CD28-activated signal transduction leading to IL-2 gene transcription and secretion. Int. Immunol 15, 1089-1098.
17. Duchniewicz, M., Zemojtel, T., Kolanczyk, M., Grossmann, S., Scheele, J. S., and Zwartkruis, F. J. (2006). Rap1A-deficient T and B cells show impaired integr in-mediated cell adhesion. Mol. Cell. Biol. 26, 643-653.
18. Dustin, M. L. (2008). T-cell activation through immunological synapses and kinapses. Immunol. Rev. 221, 77-89.
19. Dustin, M. L., Bivona, T. G., and Philips, M. R. (2004). Membranes as messengers in T cell adhesion signaling. Nat. Immunol. 5, 363-372.
20. Dustin, M. L., and Springer, T. A. (1989). T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341, 619-624.
21. Efimova, T., and Eckert, R. L. (2000). Regulation of human involucrin promoter activity by novel protein kinase C isoforms. J. Biol. Chem. 275, 1601-1607.
22. Evenou, J. P., Wagner, J., Zenke, G., Brinkmann, V., Wagner, K., Kovarik, J., Welzenbach, K. A., Weitz-Schmidt, G., Guntermann, C., Towbin, H., Cottens, S., Kaminski, S., Letschka, T., Lutz-Nicoladoni, C., Gruber, T., Hermann-Kleiter, N., Thuille, N., and Baier, G. (2009). The potent protein kinase C-selective inhibitor AEB071 (sotrastaurin) represents a new class of immunosuppressive agents affecting early T-cell activation. J. Pharmacol. Exp. Ther. 330, 792-801.
23. Fang, D., and Liu, Y. C. (2001). Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiqui-tination in T cells. Nat. Immunol. 2, 870-875.
24. Fauconnier, M., Bourigault, M. L., Meme, S., Szeremeta, F., Palomo, J., Danneels, A., Charron, S., Fick, L., Jacobs, M., Beloeil, J. C., Ryf-fel, B., and Quesniaux, V. F. (2011). Protein kinase C-9 is required for development of experimental cerebral malaria. Am. J. Pathol. 178, 212-221.
25. Formisano, P., Oriente, F., Fiory, F., Caruso, M., Miele, C., Maitan, M. A., Andreozzi, F., Vigliotta, G., Con-dorelli, G., and Beguinot, F. (2000). Insulin-activated protein kinase Cβ bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol. Cell. Biol. 20, 6323-6333.
26. Freeley, M., Volkov, Y., Kelleher, D., and Long, A. (2005). Stimulus-induced phosphorylation of PKC 9 at the C-terminal hydrophobic-motif in human T lymphocytes. Biochem. Biophys. Res. Commun. 334, 619-630.
27. Freiberg, B. A., Kupfer, H., Maslanik, W, Delli, J., Kappler, J., Zaller, D. M., and Kupfer, A. (2002). Staging and resetting T cell activation in SMACs. Nat. Immunol. 3, 911-917.
28. Fu, G., Hu, J., Niederberger-Magnenat, N., Rybakin, V., Casas, J., Yachi, P. P., Feldstein, S., Ma, B., Hoerter, J. A., Ampudia, J., Rigaud, S., Lambolez, F., Gavin, A. L., Sauer, K., Cheroutre, H., and Gascoigne, N. R. (2011). Protein kinase C eta is required for T cell activation and homeostatic proliferation. Sci. Signal. 4, ra84.
29. Garaude, J., Kaminski, S., Charni, S., Aguilo, J. I., Jacquet, C., Plays, M., Hernandez, J., Rodriguez, F., Hip-skind, R. A., Anel, A., and Villalba, M. (2008). Impaired anti-leukemic immune response in PKC9-deficient mice. Mol. Immunol. 45, 3463-3469.
30. Genot, E. M., Parker, P. J., and Cantrell, D. A. (1995). Analysis of the role of protein kinase C-a, -s, and -t, in T cell activation. J. Biol. Chem. 270, 9833-9839.
31. Gomez, J., Martinez, C., Garcia, A., and Rebollo, A. (1996). Association of phosphatidylinositol 3 kinase to protein kinase C<; during interleukin-2 stimulation. Eur. J. Immunol. 26, 1781-1787.
32. Gomez, J., Martinez De Aragon, A., Bonay, P., Pitton, C., Garcia, A., Silva, A., Fresno, M., Alvarez, F., and Rebollo, A. (1995). Physical association and functional relationship between protein kinase C <; and the actin cytoskeleton. Eur. J. Immunol. 25, 2673-2678.
33. Gorelik, G., Fang, J. Y, Wu, A., Sawalha, A. H., and Richardson, B. (2007). Impaired T cell protein kinase C § activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J. Immunol. 179, 5553-5563.
34. Graeler, M. H., Kong, Y., Karliner, J. S., and Goetzl, E. J. (2003). Protein kinase C s dependence of the recovery from down-regulation of S1P1 G protein-coupled receptors of T lymphocytes. J. Biol. Chem. 278, 27737-27741.
35. Gruber, T., Barsig, J., Pfeifhofer, C., Ghaffari-Tabrizi, N., Tinhofer, I., Leitges, M., and Baier, G. (2005). PKCS is involved in signal attenuation in CD3+ T cells. Immunol. Lett. 96, 291-293.
36. Gruber, T., Fresser, F., Jenny, M., Uberall, F., Leitges, M., and Baier, G. (2008). PKC9 cooperates with atypical PKCi; and PKCi in NF-KB tr ansactivation of T lymphocytes. Mol. Immunol. 45, 117-126.
37. Gruber, T., Hermann-Kleiter, N., Hin-terleitner, R., Fresser, F., Schneider, R., Gastl, G., Penninger, J. M., and Baier, G. (2009a). PKC9 modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. Sci. Signal. 2,ra30.
38. Gruber, T., Hermann-Kleiter, N., Pfeifhofer-Obermair, C., Lutz-Nicoladoni, C., Thuille, N., Letschka, T., Barsig, J., Baudler, M., Li, J., Metzler, B., Nusslein-Hildesheim, B., Wagner, J., Leitges, M., and Baier, G. (2009b). PKC 9 cooperates with PKC a in alloimmune responses of T cells in vivo. Mol. Immunol. 46, 2071-2079.
39. Gruber, T., Pfeifhofer-Obermair, C, and Baier, G. (2010). PKC9 is necessary for efficient activation of NFkB, NFAT,andAP-1 during positive selection of thymocytes. Immunol. Lett. 132, 6-11.
40. Gunaratne, A., Benchabane, H., and Di Guglielmo, G. M. (2012). Regulation of TGFβ receptor trafficking and signaling by atypical protein kinase C. Cell Signal. 24, 119-130.
41. Gupta, S., Manicassamy, S., Vasu, C., Kumar, A., Shang, W, and Sun, Z. (2008a). Differential requirement of PKC9 in the development and function of natural regulatory T cells. Mol. Immunol. 46, 213-224.
42. Gupta, S., Shang, W., and Sun, Z. (2008b). Mechanisms regulating the development and function of natural regulatory T cells. Arch. Immunol. Ther. Exp. (Warsz) 56, 85-102.
43. Haxhinasto, S., Mathis, D., and Benoist, C. (2008). The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205, 565-574.
44. Heissmeyer, V., Macian, F., Im, S. H., Varma, R., Feske, S., Venuprasad, K., Gu, H., Liu, Y. C, Dustin, M. L., and Rao, A. (2004). Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nat. Immunol. 5, 255-265.
45. Hermann-Kleiter, N., Gruber, T., Lutz-Nicoladoni, C, Thuille, N., Fresser, F., Labi, V., Schiefermeier, N., Warnecke, M., Huber, L., Villunger, A., Eichele, G., Kaminski, S., and Baier, G. (2008). The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 29, 205-216.
46. Hii, C. S., Costabile, M., Mayne, G. C, Der, C. J., Murray, A. W, and Fer-rante, A. (2003). Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells. Biochem. J. 370, 497-503.
47. Hirai, T., and Chida, K. (2003). Protein kinase Ci; (PKCi;): activation mechanisms and cellular functions. J. Biochem. 133, 1-7.
48. Hsieh, H. L., Wang, H. H., Wu, C. Y, Jou, M. J., Yen, M. H., Parker, P., and Yang, C. M. (2007). BK-induced COX-2 expression via PKCS-dependent activation of p42/p44 MAPK and NFKB in astrocytes. Cell Signal. 19, 330-340.
49. Ikuta, T., Chida, K., Tajima, O., Mat-suura, Y, Iwamori, M., Ueda, Y, Mizuno, K., Ohno, S., and Kuroki, T. (1994). Cholesterol sulfate, a novel activator for the eta isoform of protein kinase C. Cell Growth Differ. 5, 943-947.
50. Iwamoto, T., Hagiwara, M., Hidaka, H., Isomura, T., Kioussis, D., and Nakashima, I. (1992). Accelerated proliferation and interleukin-2 production of thymocytes by stimulation of soluble anti-CD3 monoclonal antibody in transgenic mice carrying a rabbit protein kinase C a. J. Biol. Chem. 267,18644-18648.
51. Jackson, D., Zheng, Y, Lyo, D., Shen, Y, Nakayama, K., Nakayama, K. I., Humphries, M. J., Reyland, M. E., and Foster, D. A. (2005). Suppression of cell migration by protein kinase CS. Oncogene 24, 3067-3072.
52. Jeon, M. S., Atfield, A., Venuprasad, K., Krawczyk, C, Sarao, R., Elly, C, Yang, C, Arya, S., Bachmaier, K., Su, L., Bouchard, D., Jones, R., Gronski, M., Ohashi, P., Wada, T., Bloom, D., Fathman, C. G., Liu, Y C, and Penninger, J. M. (2004). Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167-177.
53. Jones, R. G., Parsons, M., Bonnard, M., Chan, V. S., Yeh, W C, Woodgett, J. R., and Ohashi, P. S. (2000). Protein kinase B regulates T lymphocyte survival, nuclear factor KB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191,1721-1734.
54. Kang, S. W., Wahl, M. I., Chu, J., Kitaura, J., Kawakami, Y, Kato, R. M., Tabuchi, R., Tarakhovsky, A., Kawakami, T., Turck, C. W, Witte, O. N., and Rawl-ings, D. J. (2001). PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 20, 5692-5702.
55. Kashiwagi, M., Ohba, M., Watan-abe, H., Ishino, K., Kasahara, K., Sanai, Y., Taya, Y., and Kuroki, T. (2000). PKCeta associates with cyclin E/cdk2/p21 complex, phos-phorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene 19, 6334-6341.
56. Katagiri, K., Hattori, M., Minato, N., and Kinashi, T. (2002). Rap1 functions as a key regulator of T-cell and antigen-presenting cell interactions and modulates T-cell responses. Mol. Cell Biol. 22, 1001-1015.
57. Keenan, C, Volkov, Y, Kelleher, D., and Long, A. (1997). Subcellular localization and translocation of protein kinase C isoforms <; and s in human peripheral blood lymphocytes. Int. Immunol 9,1431-1439.
58. Kikkawa, U., Matsuzaki, H., and Yamamoto, T. (2002). Protein kinase C S (PKC S): activation mechanisms and functions.J. Biochem. 132, 831-839.
59. Koizumi, H., Kohno, Y., Osada, S., Ohno, S., Ohkawara, A., and Kuroki, T. (1993). Differentiation-associated localization of nPKC eta, a Ca(++)-independent protein kinase C, in normal human skin and skin diseases. J. Invest Dermatol 101, 858-863.
60. Kong, K. F., Yokosuka, T., Canonigo-Balancio, A. J., Isakov, N., Saito, T., and Altman, A. (2011). A motif in the V3 domain of the kinase PKC9 determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol 12, 1105-1112.
61. Kumar, S., Sieghart, W., and Morrow, A. L. (2002). Association of protein kinase C with GABA(A) receptors containing alpha1 and alpha4 sub-units in the cerebral cortex: selective effects of chronic ethanol consumption.J. Neurochem. 82, 110-117.
62. Kwon, M. J., Ma, J., Ding, Y, Wang, R., and Sun, Z. (2012). Protein kinase C-9 promotes Th17 differentiation via upregulation of Stat3. J. Immunol 188, 5887-5897.
63. Lallena, M. J., Diaz-Meco, M. T., Bren, G., Paya, C. V., and Moscat, J. (1999). Activation of IKB kinase β by protein kinase C isoforms. Mol Cell Biol. 19, 2180-2188.
64. Lee, K. Y., D'Acquisto, F., Hayden, M. S., Shim, J. H., and Ghosh, S. (2005). PDK1 nucleates T cell receptor-induced signaling complex for NF-KB activation. Science 308, 114-118.
65. Leitges, M., Schmedt, C., Guinamard, R., Davoust, J., Schaal, S., Sta-bel, S., and Tarakhovsky, A. (1996). Immunodeficiency in protein kinase cbeta-deficient mice. Science 273, 788-791.
66. Leroy, I., De Thonel, A., Laurent, G., and Quillet-Mary, A. (2005). Protein kinase C <; associates with death inducing signaling complex and regulates Fas ligand-induced apoptosis. CellSignal 17, 1149-1157.
67. Letschka, T., Kollmann, V., Pfeifhofer-Obermair, C., Lutz-Nicoladoni, C., Obermair, G. J., Fresser, F., Leitges, M., Hermann-Kleiter, N., Kamin-ski, S., and Baier, G. (2008). PKC9 selectively controls the adhesion-stimulating molecule Rap1. Blood 112, 4617-4627.
68. Li, L., Lorenzo, P. S., Bogi, K., Blum-berg, P. M., and Yuspa, S. H. (1999). Protein kinase CS targets mitochondria, alters mitochondrial membrane potential, and induces apoptosis in normal and neoplastic keratinocytes when overexpressed by an adenoviral vector. Mol. Cell. Biol. 19, 8547-8558.
69. Liu, Y, Graham, C., Li, A., Fisher, R. J., and Shaw, S. (2002). Phosphorylation of the protein kinase C-9 activation loop and hydrophobic motif regulates its kinase activity, but only activation loop phosphorylation is critical to in vivo nuclear-factor-KB induction. Biochem. J. 361, 255-265.
70. Liu, Y, Witte, S., Liu, Y C., Doyle, M., Elly, C., and Altman, A. (2000). Regulation of protein kinase C9 function during T cell activation by Lck-mediated tyrosine phosphorylation. J. Biol. Chem. 275, 3603-3609.
71. Lomonaco, S. L., Kahana, S., Blass, M., Brody, Y., Okhrimenko, H., Xiang, C., Finniss, S., Blumberg, P. M., Lee, H. K., and Brodie, C. (2008). Phosphorylation of protein kinase CS on distinct tyrosine residues induces sustained activation of Erk1/2 via down-regulation of MKP-1: role in the apoptotic effect of etoposide. J. Biol. Chem. 283, 17731-17739.
72. Long, A., Kelleher, D., Lynch, S., and Volkov, Y (2001). Cutting edge: protein kinase C β expression is critical for export of Il-2 from T cells. J. Immunol. 167,636-640.
73. Lu, W., Finnis, S., Xiang, C, Lee, H. K., Markowitz, Y, Okhrimenko, H., and Brodie, C. (2007). Tyrosine 311 is phosphorylated by c-Abl and promotes the apoptotic effect of PKCS in glioma cells. Biochem. Biophys. Res. Commun. 352, 431-436.
74. Lub, M., Van Kooyk, Y, and Figdor, C. G. (1995). Ins and outs of LFA-1. Immunol. Today 16,479-483.
75. Lutz-Nicoladoni, C, Letschka, T., Leitges, M., Villunger, A., and Baier, G. (2005). Essential role of PKCS in apoptosis induction of mouse thymocytes. Am. J. Immunol. 1, 14-20.
76. Ma, J., Ding, Y, Fang, X., Wang, R., and Sun, Z. (2012). Protein kinase C-9 inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway. J. Immunol. 188, 5337-5347.
77. Ma, J. S., Haydar, T. F., and Radoja, S. (2008). Protein kinase C S localizes to secretory lysosomes in CD8+ CTL and directly mediates TCR signals leading to granule exocytosis-mediated cytotoxicity. J. Immunol. 181, 4716-4722.
78. Ma, J. S., Monu, N., Shen, D. T., Meck-lenbrauker, I., Radoja, N., Haydar, T. F., Leitges, M., Frey, A. B., Vuk-manovic, S., and Radoja, S. (2007). Protein kinase CS regulates antigen receptor-induced lytic granule polarization in mouse CD8+ CTL. J. Immunol. 178,7814-7821.
79. Majumder, P. K., Mishra, N. C, Sun, X., Bharti, A., Kharbanda, S., Saxena, S., andKufe,D. (2001). Targeting of protein kinase C S to mitochondria in the oxidative stress response. Cell Growth Differ. 12, 465-470.
80. Marsland, B. J., Soos, T. J., Spath, G., Littman, D. R., and Kopf, M. (2004). Protein kinase C 9 is critical for the development of in vivo T helper (Th)2 cell but not Th1 cell responses. J. Exp. Med. 200, 181-189.
81. Martin, A. G., San-Antonio, B., and Fresno, M. (2001). Regulation of nuclear factor K B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C ́ in c-Rel activation by tumor necrosis factor a. J. Biol. Chem. 276, 15840-15849.
82. Martin, P., Villares, R., Rodriguez-Mascarenhas, S., Zaballos, A., Leitges, M., Kovac, J., Sizing, I., Rennert, P., Marquez, G., Martinez, A. C, Diaz-Meco, M. T., and Moscat, J. (2005). Control of T helper 2 cell function and allergic airway inflammation by PKCi;. Proc. Natl. Acad. Sci. U.S.A. 102, 9866-9871.
83. Maulon, L., Mari, B., Bertolotto, C, Ricci, J. E., Luciano, F., Belhacene, N., Deckert, M., Baier, G., and Auberger, P. (2001). Differential requirements for ERK1/2 and P38 MAPK activation by thrombin in T cells. Role of P59Fyn and PKCs. Oncogene 20, 1964-1972.
84. Mazerolles, F., Lumbroso, C, Lecomte, O., Le Deist, F., and Fischer, A. (1988). The role of lymphocyte function-associated antigen 1 (LFA-1) in the adherence of T lymphocytes to B lymphocytes. Eur. J. Immunol. 18, 1229-1234.
85. Meng, X. W., Heldebrant, M. P., Flatten, K. S., Loegering, D. A., Dai, H., Schneider, P. A., Gomez, T. S., Peterson, K. L., Trushin, S. A., Hess, A. D., Smith, B. D., Karp, J. E., Billadeau, D. D.,andKaufmann, S. H. (2010). Protein kinase Cbeta modulates ligand-induced cell surface death receptor accumulation: a mechanistic basis for enzastaurin-death ligand synergy. J. Biol. Chem. 285, 888-902.
86. Michie, A. M., Soh, J. W, Hawley, R. G., Weinstein, I. B., andZuniga-Pflucker, J. C. (2001). Allelic exclusion and differentiation by protein kinase C-mediated signals in immature thymo-cytes. Proc. Natl. Acad. Sci. U.S.A. 98, 609-614.
87. Mirandola, P., Gobbi, G., Masselli, E., Micheloni, C, Di Marcanto-nio, D., Queirolo, V, Chiodera, P., Meschi, T., and Vitale, M. (2011). Protein kinase Cs regulates proliferation and cell sensitivity to TGF-1β of CD4+ T lymphocytes: implications for Hashimoto thyroiditis. J. Immunol. 187,4721-4732.
88. Mischak, H., Kolch, W, Goodnight, J., Davidson, W F., Rapp, U., Rose-John, S., and Mushinski, J. F. (1991). Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific. J. Immunol. 147,3981-3987.
89. Miscia, S., Ciccocioppo, F., Lanuti, P., Velluto, L., Bascelli, A., Pierdomenico, L., Genovesi, D., Di Siena, A., San-tavenere, E., Gambi, F., Ausili-Cefaro, G., Grimley, P. M., Marchisio, M., and Gambi, D. (2009). A β(1-42) stimulated T cells express P-PKCS and P-PKCi; in Alzheimer disease. Neurobiol Aging 30, 394-406.
90. Morley, S. C, Weber, K. S., Kao, H., and Allen, P. M. (2008). Protein kinase C-9 is required for efficient positive selection. J. Immunol. 181, 4696-4708.
91. Morrow, T. A., Muljo, S. A., Zhang, J., Hardwick, J. M., and Schlissel, M. S. (1999). Pro-B-cell-specific transcription and proapoptotic function of protein kinase Ceta. Mol. Cell. Biol. 19, 5608-5618.
92. Nakagawa, M., Oliva, J. L., Kothapalli, D., Fournier, A., Assoian, R. K., and Kazanietz, M. G. (2005). Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase CS-dependent induction of p21. J. Biol. Chem. 280, 33926-33934.
93. Naramura, M., Jang, I. K., Kole, H., Huang, F., Haines, D., and Gu, H. (2002). c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat. Immunol. 3, 1192-1199.
94. Nechushtan, H., Leitges, M., Cohen, C, Kay, G., and Razin, E. (2000). Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta. Blood 95,1752- 1757.
95. Nishanth, G., Sakowicz-Burkiewicz, M., Handel, U., Kliche, S., Wang, X., Naumann, M., Deckert, M., and Schluter, D. (2010). Protective Toxoplasma gondii -specific T-cell responses require T-cell-specific expression of protein kinase C-9. Infect Immun. 78, 3454-3464.
96. Oh, J. W., Kim, E. Y., Koo, B. S., Lee, H. B., Lee, K. S., Kim, Y. S., and Han, J. S. (2004). Der f 2 activates phos-pholipase D in human T lymphocytes from Dermatophagoides farinae specific allergic individuals: involvement of protein kinase C-a. Exp. Mol. Med. 36,486-492.
97. Osada, S., Mizuno, K., Saido, T. C., Akita, Y, Suzuki, K., Kuroki, T., and Ohno, S. (1990). A phorbol ester receptor/protein kinase, nPKC eta, a new member of the protein kinase C family predominantly expressed in lung and skin. J. Biol. Chem. 265, 22434-22440.
98. Penninger, J. M., and Crabtree, G. R. (1999). The actin cytoskeleton and lymphocyte activation. Cell 96, 9-12.
99. Perrini, S., Natalicchio, A., Laviola, L., Belsanti, G., Montrone, C., Cignarelli, A., Minielli, V., Grano, M., De Pergola, G., Giorgino, R., and Giorgino, F. (2004). Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane. Diabetes 53, 41-52.
100. Pfeifhofer, C., Gruber, T., Letschka, T., Thuille, N., Lutz-Nicoladoni, C., Hermann-Kleiter, N., Braun, U., Leitges, M., and Baier, G. (2006). Defective IgG2a/2b class switching in PKC a-/- mice. J. Immunol. 176, 6004-6011.
101. Pfeifhofer, C., Kofler, K., Gruber, T., Tabrizi, N. G., Lutz, C., Maly, K., Leitges, M., and Baier, G. (2003). Protein kinase C 9 affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197,1525-1535.
102. Quan, T., and Fisher, G. J. (1999). Cloning and characterization of the human protein kinase C-eta promoter. J. Biol. Chem. 274, 28566-28574.
103. Quann, E. J., Liu, X., Altan-Bonnet, G., and Huse, M. (2011). A cascade of protein kinase C isozymes promotes cytoskeletal polarization in T cells. Nat. Immunol. 12, 647-654.
104. Rao, K. L., Varalakshmi, C, Kumari, A L., and Khar, A. (1999). Inter action between B.7 and CD28 costimulatory molecules is essential for the activation of effector function mediating spontaneous tumour regression. Scand. J. Immunol. 49,633-640.
105. Real, E., Faure, S., Donnadieu, E., and Delon, J. (2007). Cutting edge: atypical PKCs regulate T lymphocyte polarity and scanning behavior. J. Immunol. 179, 5649-5652.
106. Sakaguchi, S., Yamaguchi, T., Nomura, T.,and Ono, M. (2008). Regulatory T cells and immune tolerance. Cell 133, 775-787.
107. Sakowicz-Burkiewicz, M., Nishanth, G., Helmuth, U., Drogemuller, K., Busch, D. H., Utermohlen, O., Naumann, M., Deckert, M., and Schluter, D. (2008). Protein kinase C-9 critically regulates the proliferation and survival of pathogen-specific T cells in murine listeriosis. J. Immunol. 180, 5601-5612.
108. Salek-Ardakani, S., So, T., Halteman, B. S., Altman, A., and Croft, M. (2004). Differential regulation of Th2 and Th1 lung inflammatory responses by protein kinase C 9. J. Immunol. 173, 6440-6447.
109. Salek-Ardakani, S., So, T., Halteman, B S., Altman, A., and Croft, M. (2005). Protein kinase C9 controls The cells in experimental autoimmune encephalomyelitis. J. Immunol. 175, 7635-7641.
110. San-Antonio, B., Iniguez, M. A., and Fresno, M. (2002). Protein kinase C; phosphorylates nuclear factor of activated T cells and regulates its trans-activating activity. J. Biol. Chem. 277, 27073-27080.
111. Sanchez-Valdepenas, C, Punzon, C, San-Antonio, B., Martin, A. G., and Fresno, M. (2007). Differential regulation of p65 and c-Rel NF-KB trans-activating activity by Cot, protein kinase C <; and NIK protein kinases in CD3/CD28 activated T cells. Cell Signal. 19,528-537.
112. Santiago-Walker, A. E., Fikaris, A. J., Kao, G. D., Brown, E. J., Kazani-etz, M. G., and Meinkoth, J. L. (2005). Protein kinase C § stimulates apoptosis by initiating G1 phase cell cycle progression and S phase arrest. J. Biol. Chem. 280, 32107-32114.
113. Satoh, A., Gukovskaya, A. S., Nieto, J. M., Cheng, J. H., Gukovsky, I., Reeve, J. R. Jr., Shimosegawa, T., and Pandol, S. J. (2004). PKCS and -s regulate NF-KB activation induced by cholecystokinin and TNF-a in pancreatic acinar cells. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G582-591.
114. Sauer, S., Bruno, L., Hertweck, A., Fin-lay, D., Leleu, M., Spivakov, M., Knight, Z. A., Cobb, B. S., Cantrell, D., O'Connor, E., Shokat, K. M., Fisher, A. G., and Merkenschlager, M. (2008). T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 105, 7797-7802.
115. Schaefer, B. C, Kappler, J. W., Kupfer, A., and Marrack, P. (2004). Complex and dynamic redistribution of NF-KB signaling intermediates in response to T cell receptor stimulation. Proc. Natl. Acad. Sci. U.S.A. 101, 1004-1009.
116. Scheel-Toellner, D., Pilling, D., Akbar, A. N., Hardie, D., Lombardi, G., Salmon, M., and Lord, J. M. (1999). Inhibition of T cell apoptosis by IFN-β rapidly reverses nuclear translocation of protein kinase C-S. Eur. J. Immunol. 29, 2603-2612.
117. Shevach, E. M. (2009). Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30, 636-645.
118. Shimonaka, M., Katagiri, K., Nakayama, T., Fujita, N., Tsuruo, T., Yoshie, O., and Kinashi, T. (2003). Rap1 translates chemokine signals to inte-grin activation, cell polarization, and motility across vascular endothelium under flow. J. Cell Biol. 161, 417-427.
119. Simon, A. K., Auphan, N., Pophillat, M., Boyer, C, Ghosh, S., Rincon, M., Flavell, R. A., and Schmitt-Verhulst, A. M. (2000). The lack of NF-KB transactivation and PKC s expression in CD4(+)CD8(+) thymocytes correlates with negative selection. Cell Death Differ. 7, 1253-1262.
120. Skvara, H., Dawid, M., Kleyn, E., Wolff, B., Meingassner, J. G., Knight, H., Dumortier, T., Kopp, T., Fallahi, N., Stary, G., Burkhart, C, Grenet, O., Wagner, J., Hijazi, Y, Morris, R. E., Mcgeown, C, Rordorf, C, Griffiths, C. E., Stingl, G., and Jung, T. (2008). The PKC inhibitor AEB071 may be a therapeutic option for psoriasis. J. Clin. Invest. 118, 3151-3159.
121. Solstad, T., Bjorgo, E., Koehler, C. J., Strozynski, M., Torgersen, K. M., Tasken, K., and Thiede, B. (2010). Quantitative proteome analysis of detergent-resistant membranes identifies the differential regulation of protein kinase C isoforms in apop-totic T cells. Proteomics 10, 2758-2768.
122. Sommer, K., Guo, B., Pomerantz, J. L., Bandaranayake, A. D., Moreno-Garcia, M. E., Ovechkina, Y. L., and Rawlings, D. J. (2005). Phosphorylation of the CARMA1 linker controls NF-KB activation. Immunity 23, 561-574.
123. Sun, Z., Arendt, C. W, Ellmeier, W., Schaeffer, E. M., Sunshine, M. J., Gandhi, L., Annes, J., Petrzilka, D., Kupfer, A., Schwartzberg, P. L., and Littman, D. R. (2000). PKC9 is required for TCR-induced NF-KB activation in mature but not immature T lymphocytes. Nature 404, 402-407.
124. Szamel, M., Appel, A., Schwinzer, R., and Resch, K. (1998). Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J. Immunol. 160, 2207-2214.
125. Takai, Y, Kishimoto, A., Inoue, M., and Nishizuka, Y (1977). Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J. Biol. Chem. 252, 7603-7609.
126. Tan, S. L., Zhao, J., Bi, C, Chen, X. C, Hepburn, D. L., Wang, J., Sedgwick, J. D., Chintalacharuvu, S. R., and Na, S. (2006). Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C 9-deficient mice. J. Immunol. 176, 2872-2879.
127. Thornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y, and Shevach, E. M. (2010). Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J. Immunol. 184, 3433-3441.
128. Thuille, N., Gruber, T., Bock, G., Leitges, M., and Baier, G. (2004). Protein kinase C β is dispensable for TCR-signaling. Mol. Immunol. 41, 385-390.
129. Thuille, N., Heit, I., Fresser, F., Krum-bock, N., Bauer, B., Leuthaeusser, S., Dammeier, S., Graham, C, Copeland, T. D., Shaw, S., and Baier, G. (2005). Critical role of novel Thr-219 auto phosphorylation for the cellular function of PKC9 in T lymphocytes. EMBO J. 24, 3869-3880.
130. Trucy, M., Barbat, C, Fischer, A., and Mazerolles, F. (2006). CD4 ligation induces activation of protein kinase C t, and phosphoinositide-dependent-protein kinase-1, two kinases required for down-regulation of LFA-1-mediated adhesion. Cell Immunol 244, 33-42.
131. Trushin, S. A., Pennington, K. N., Carmona, E. M., Asin, S., Savoy, D. N., Billadeau, D. D., and Paya, C. V. (2003). Protein kinase Ca (PKCa) acts upstream of PKC9 to activate IKB kinase and NF-KB in T lymphocytes. Mol. Cell. Biol. 23, 7068-7081.
132. Ueda, E., Ohno, S., Kuroki, T., Livneh, E., Yamada, K., Yaman-ishi, K., and Yasuno, H. (1996). The eta isoform of protein kinase C mediates transcriptional activation of the human transglutaminase 1 gene. J. Biol. Chem. 271, 9790-9794.
133. Volkov, Y, Long, A., and Kelle-her, D. (1998). Inside the crawling T cell: leukocyte function-associated antigen-1 cross-linking is associated with microtubule-directed translocation of protein kinase C isoenzymes β(I) and S. J. Immunol. 161, 6487-6495.
134. Volkov, Y, Long, A., Mcgrath, S., Ni Eidhin, D., and Kelleher, D. (2001). Crucial importance of PKCβ(I) in LFA-1-mediated locomotion of activated T cells. Nat. Immunol. 2, 508-514.
135. von Essen, M., Nielsen, M. W., Bone-feld, C. M., Boding, L., Larsen, J. M., Leitges, M., Baier, G., Odum, N., and Geisler, C. (2006). Protein kinase C (PKC) a and PKC 9 are the major PKC isotypes involved in TCR down-regulation. J. Immunol. 176, 7502-7510.
136. Watanabe, T., Ono, Y, Taniyama, Y, Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U., and Nishizuka, Y (1992). Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-S subspecies. Proc. Natl. Acad. Sci. U.S.A. 89, 10159-10163.
137. Yang, D., Guo, J., Divieti, P., and Bringhurst, F. R. (2006). Parathyroid hormone activates PKCS and regulates osteoblastic differentiation via a PLC-independent pathway. Bone 38, 485-496.
138. Zanin-Zhorov, A., Dustin, M. L., and Blazar, B. R. (2011). PKC9 function at the immunological synapse: prospects for therapeutic targeting. Trends Immunol. 32, 358-363.
139. Zhang, H. W., Yang, Y., Zhang, K., Qiang, L., Yang, L., Hu, Y., Wang, X. T., You, Q. D., and Guo, Q. L. (2008). Wogonin induced differentiation and G1 phase arrest of human U-937 leukemia cells via PKCS phosphorylation. Eur. J. Pharmacol. 591, 7-12.
140. Zheng, Y, and Rudensky, A. Y (2007). Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462.